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ABSTRACT Proﬁlin, a small cytoskeletal protein, and phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] have been implicated
in cellular events that alter the cell morphology, such as endocytosis, cell motility, and formation of the cleavage furrow during
cytokinesis. Proﬁlin has been shown to interact with PI(4,5)P2, but the role of this interaction is still poorly understood. Using giant
unilamellar vesicles (GUVs) as a simple model of the cell membrane, we investigated the interaction between proﬁlin and
PI(4,5)P2. A number and brightness analysis demonstrated that in the absence of proﬁlin, molar ratios of PI(4,5)P2 above 4%
result in lipid demixing and cluster formations. Furthermore, adding proﬁlin to GUVs made with 1% PI(4,5)P2 leads to the forma-
tion of clusters of both proﬁlin and PI(4,5)P2. However, due to the self-quenching of the dipyrrometheneboron diﬂuoride-labeled
PI(4,5)P2, we were unable to determine the size of these clusters. Finally, we show that the formation of these clusters results in
the destabilization and deformation of the GUV membrane.INTRODUCTION
Most investigations of the interaction between membrane
lipids and proteins have been performed using either model
systems that provide only averaged parameters from bulk
data collected from solutions containing many liposomes,
or in cellulo systems. The latter are often so complex that
primary effects due to protein-lipid interactions are very
difficult to observe and analyze. The giant unilamellar
vesicle (GUV) has emerged as a model system that can
bridge the gap between the bulk data collection (i.e., lipo-
somes) and cells. The low curvature of GUV membranes
closely resembles that of native cells, whereas other vesicles
have much higher curvatures that could affect the interaction
between proteins and lipids. Of importance, one can visu-
alize and image spatially confined events in GUVs at the
level of single vesicles in a controlled system that is much
simpler than a cell. In the last 3 years, several groups have
successfully used the GUV system to study protein phospha-
tidylinositol (4,5)-bisphosphate [PI(4,5)P2] interactions
(1–8). In this study, we expand on our previous work (7)
and further characterize the interaction between profilin
and PI(4,5)P2.
PI(4,5)P2 is an important dynamic component of the
plasmamembrane and constitutes ~1% of the total membrane
lipids in human erythrocytes (9). Despite its relatively low
concentration, PI(4,5)P2 plays several important roles in
cellular events, including endocytosis/exocytosis (10–12)
and normal cytokinesis (13,14).
PI(4,5)P2 interacts with several proteins that are involved
in membrane secretion and actin cytoskeleton remodeling.
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0006-3495/09/06/5112/10 $2.00One of these ligands is profilin I, a 14 kDa actin sequestering
protein (15). Profilin I is a ubiquitous eukaryotic protein that
has been shown to play pivotal roles in many cellular func-
tions.
Profilin gene disruption has led to similar defects in
different organisms. In Saccharomyces cerevisiae, the
disruption led to the formation of larger (sometimes by up
to 50 times) undivided, multinucleated cells due to defective
cytokinesis (16). In Dictyostelium discoideum, profilin
disruption causes the cell size to increase by up to 10 times,
as in the case of Saccharomyces cerevisiae, in which motility
was shown to be severely affected and development blocked
before fruiting-body formation (17). In normal bovine
embryos, profilin was found to be concentrated at the
cleavage furrow in 56% of the embryos (18). A similar local-
ization of profilin in cleavage furrows was observed earlier in
Tetrahymena (19), suggesting that profilin may facilitate cell
division. The suppression of profilin I by RNA interference
in human umbilical vein endothelial cells produced a signifi-
cant reduction of the formation of actin filament and cell
adhesion. The absence of profilin was also responsible for
a significant reduction in cell protrusions (20).
In human platelets, profilin partitions between the plasma
membrane and the cytosol in response to membrane
PI(4,5)P2 levels (21). This interaction of profilin with
PI(4,5)P2 has been partially assigned to binding of the nega-
tively charged headgroup of the phosphoinositides to basic
amino acids (22,23). In a previous study (7), we proposed
that the initial interaction of profilin with PI(4,5)P2 lipids
may require more than one PI(4,5)P2 and/or that the
membrane is an essential component of the profilin interac-
tion with PI(4,5)P2. Our GUV data also suggest that profilin
is able to recruit adjacent PI(4,5)P2 lipids. Recent studies on
doi: 10.1016/j.bpj.2009.03.034
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(24), and the basic effector domain of myristoylated alanine-
rich C kinase substrate (MARCKS) (25) all indicate clus-
tering of PI(4,5)P2 phospholipids upon protein binding.
We demonstrated in our previous work that the short-chain
(C6) dipyrrometheneboron difluoride (BODIPY)-labeled
polyphosphoinositide (PPI) lipids partition to the membrane
only under specific conditions (7). Using the z-potential,
Carvalho et al. (8) recently demonstrated that the long-chain
C16 fluorescent PI(4,5)P2 analogs are effectively incorpo-
rated into the GUV membrane. Therefore, we can use
C16-labeled PI(4,5)P2 to better characterize the interaction
between profilin and the GUV membrane.
In this work, we show that the interaction of profilin with
PI(4,5)P2 destabilizes the GUV membrane. This destabiliza-
tion results in altered GUV morphology. We demonstrate
that profilin and PI(4,5)P2 form clusters on the membrane,
and that some of these clusters are localized at the sites of
morphological alterations. Finally, we show that increasing
the concentration of PI(4,5)P2 in the GUV results in lipid
demixing and cluster formation, leading to morphological




GUVs were prepared by the electroformation method first described by
Angelova et al. (26), with the GUV chamber described by Fidorra et al.
(27). BODIPY TMR PI(4,5)P2 was purchased from Echelon Biosciences
(Salt Lake City, UT). Unlabeled L-a-phosphatidylinositol-4,5-bisphosphate
[PI(4,5)P2] (Brain, Porcine-Triammonium Salt) and 1-palmitoyl 2-oleoyl-
phosphatidylcholine (POPC) were purchased from Avanti Lipids (Alabaster,
AL). The POPC, BODIPY TMR PI(4,5)P2, and unlabeled PI(4,5)P2 stocks
were prepared in chloroform methanol mix 2:1 (v/v). The GUVs used to
investigate the profilin interaction with PI(4,5)P2 were made of 99%
POPC and 1% BODIPY TMR PI(4,5)P2 (mole fraction). The GUVs used
to study the effect of the increased PI(4,5)P2 concentration were made of
POPC, BODIPY TMR PI(4,5)P2, and unlabeled PI(4,5)P2 at different molar
ratios (99:1:0, 90:1:9, 90:10:0, 80:1:19, 80:20:0, 60:1:39, and 0:100:0) as
required. The GUVs were grown as previously described (7) (for details
see the Supporting Material).
Site-directed mutagenesis of proﬁlin I
The plasmid containing human profilin I was mutated to introduce cysteine
at position 57 by the overlapping polymerase chain reaction technique. The
primers (GeneWorks, Hindmarsh, Australia) used were TCCTGGTTGGCA
AAGACCGGTGTAGTTTTTACGTG and CCGGTCTTTGCCAACCAG
GACACCCACCTC for S57C. The mutations were confirmed by
sequencing using the pETBlue Up and Down primers (Novagen 70603
and 70604, respectively; Novagen, Darmstadt, Germany).
Labeling of proﬁlin I mutant
Profilin cloning and purification were performed as described by Moens and
Bagatolli (7) (for details see the SupportingMaterial). Then 5-iodoacetamido-
fluorescein (5-IAF), a thiol-reactive label (catalogue No. I-30451; Molecular
Probes, Carlsbad, CA) dissolved in dimethylformamide was added to thepurified profilin mutants in 50 mM Tris buffer pH 7.5 at a 1:5 ratio of protein
to label with constant stirring. The reaction was allowed to proceed for 1 h at
room temperature and free labels were separated from bound using PD-10
columns (catalogue No. 17-0851-01; Amersham Biosciences, Piscataway,
NJ). The eluted labeled profilin was dialyzed using 5 kDa cutoff membrane
against a large volume of 50 mM Tris pH 7.5 and concentrated on a 5 kDa
cutoff Amicon Ultra centrifugal filter (catalogue No. UFC900524; Millipore,
Billerica, MA).
Confocal microscopy
The GUVs were observed in a confocal fluorescence microscope (Nikon C1
with a Ti-E motorized inverted microscope) using a Plan Apochromat,
VC60x WI, 1.2 NA objective lens). The pinhole was set at 33 mM. Laser
lines at 488 and 532 nm were used for excitation of 5-IAF and BODIPY
TMR PI(4,5)P2, respectively.
Number and brightness analysis
For the number and brightness analysis, 100 frames of 256  256 pixels
each were taken. The pixel size was 49.7 nm with a pixel dwell time of
20 ms. These image stacks were analyzed using SimFCS software (Labora-
tory for Fluorescence Dynamics, University of California, Irvine, CA). The
analog detector calibration was obtained from background image stacks
taken before and after the experimental image stacks using the exact same
settings but with the laser turned off as described previously (28). No differ-
ences were found in the detector calibration between the two sets of images.
The software allows selection of areas of the images that have the same
apparent brightness (B). B ¼ 1 values represent the immobile fraction of
the image, and B > 1 values represent the mobile fraction (28). To obtain
the molecular brightness in photons/molecule/s, we divide the B  1 value
by the pixel dwell time.
Fluorescence spectroscopy
Excitation and emission spectra of 1% BODIPY TMR PI(4,5)P2 GUV and
100% BODIPY TMR PI(4,5)P2 were recorded on an ISS PC1 spectroflu-
orimeter (ISS, Champaign, IL) equipped with a 300 W Xenon arc lamp.
For the excitation spectrum, the emission wavelength was set at 580 nm
and the excitation was scanned from 380 nm to 564 nm. For the emission
spectrum, the excitation wavelength was set at the maximum of the excita-
tion spectrum, i.e., 537 nm for the 100% BODIPY TMR PI(4,5)P2 solution
and 547 nm for the 1% BODIPY TMR PI(4,5)P2 GUV solution, respec-
tively. The emission was then scanned from 555 nm to 650 nm. Three
spectra for each sample were recorded and then normalized, and the
average spectrum for each sample was calculated from the three normalized
spectra.
Fluorescence lifetime measurements
Fluorescence lifetime measurements were performed with a laser-based fluo-
rometer for time-resolved fluorescence measurements equipped with a super-
continuum fiber laser source SC450-2 from Fianium (Southampton, UK).
For a description of the experimental setup, see the Supporting Material.
All measurements were performed using excitation and emission polarizers
in magic-angle orientations. The sample holder was connected to a water
bath, which kept the sample at 20C. The B&H discriminator threshold level
was set to 100 mV during all measurements. After the samples were
measured by time-correlated single photon counting, the instrument
response function was determined with the use of a scattering solution
that directed excitation light onto the photomultiplier tube. The scattering
solution consisted of glycogen dissolved in water (glycogen from oyster,
Type II, G8751; Sigma-Aldrich, St. Louis, MO). The two lifetime compo-
nents of the fluorescence decay curve were then obtained by deconvolution
of the fluorescence curve from the instrument response function.Biophysical Journal 96(12) 5112–5121
5114 Krishnan et al.FIGURE 1 GUV containing 99% POPC and 1%
BODIPY TMR-labeled PI(4,5)P2. (A) Confocal micros-
copy image of a GUV in the absence of profilin. (B) Intensity
map of theGUVmembrane. (C) The highlighted pixels corres-
pond to a molecular brightness of 1.070. (D) Brightness
map of the same GUV membrane.RESULTS
PI(4,5)P2 incorporation into GUV
GUVs with 1% BODIPY TMR PI(4,5)P2 and 99% POPC
were prepared and observed directly in the growing chamber
or in microscopy chambers by exciting the BODIPY TMR
PI(4,5)P2 at 532 nm. The emission was detected through
a 605/75 nm bandpass barrier filter. As recently reported
by Carvalho et al. (8), the long-chain (C16) BODIPY
TMR-labeled PI(4,5)P2 are effectively incorporated into
the GUV membrane. Most of the GUVs formed ranged
in diameter from 10 to 40 mm. As illustrated in Fig. 1, A
and B, vesicles were spherical and did not present obvious
membrane alterations; <5% of the GUV population pre-
sented vesicle inclusions or junctions with other vesicles,
or were found to be multilamellar (data not shown).
Brightness analysis demonstrated that the BODIPY TMR
PI(4,5)P2 is uniformly distributed in the membrane. The
brightness calculated for this GUV (Fig. 1 B) was B ¼
1.070, giving an average of 3470 photons/molecule/s (pixel
dwell time ¼ 20 ms). When the pixels corresponding to that
brightnesswere selected, the entiremembranewas highlighted
(Fig. 1 C), demonstrating that the brightness is homogeneous
(Fig. 1D). These data show that there is no aggregation or clus-
tering of the BODIPY TMR PI(4,5)P2 at the 1% molar ratio.
The GUVs could still be observed after 3 days in the micro-
scope chamber, with no noticeable alteration of their
morphology (data not shown).Biophysical Journal 96(12) 5112–5121Proﬁlin-I binding to PI(4,5)P2 on GUV membrane
In a recent study (7), we indirectly assessed the binding of
profilin to the GUV membrane by looking at the resistance
to fluorescence resonance energy transfer (FRET) when
profilin interacted with the lipids. In the work presented
here, we used labeled lipids with a C16 alkyl chain, and
expressed and purified a cysteine mutant of profilin that
could be specifically labeled with 5-IAF and could there-
fore be directly visualized on the GUV membrane. Labeled
profilin mixed with wild-type profilin in a 1:1500 molar
ratio was added to GUVs made of 99% POPC and 1%
unlabeled PI(4,5)P2 at a final concentration of ~55 mM.
Fig. 2 clearly confirms that profilin binds to the GUV
membrane. It also shows that profilin aggregates in clusters
on the membrane.
The brightness analysis distinguished between two
populations of profilin. One population had a brightness of
B¼ 1.11 (Fig. 2 B), which for a pixel dwell time of 20 ms gives
an average of 5500 photons/mol/s, and the other population
(Fig. 2 C) had a brightness of B ¼ 1.23, giving an average of
11,500 photons/mol/s. Since the brightness depends on the
specific fluorophore and the laser power, these values cannot
be compared with the brightness of the BODIPY TMR
PI(4,5)P2 obtained from a different image, which was calcu-
lated to be B ¼ 1.071, giving an average molecular bright-
ness of 3550 photons/mol/s (Fig. 1, C and D). However,
we can compare brightness values obtained within the
Proﬁlin Destabilizes the GUV Membrane 5115FIGURE 2 Confocal microscopy image of 5-IAF-
labeled profilin binding on a GUV made of 99% POPC
and 1% unlabeled PI(4,5)P2. (A) Intensity map of the
GUV membrane. (B) The highlighted pixels correspond
to a molecular brightness of 1.11. (C) The highlighted
pixels are clusters of profilin and correspond to a molecular
brightness of 1.23. (D) Brightness map of the same GUV
membrane.same images. In these cases, the different brightness values
correspond to particles of different sizes. The ratio of molec-
ular brightness between the two populations of fluorophores
in Fig. 2, B and C, is equal to 2.1, suggesting that profilin
forms dimers when interacting with PI(4,5)P2. However, to
be able to visualize the binding of profilin to the GUV
membrane, we diluted the labeled profilin by a factor of
1500 with unlabeled profilin so that the labeled profilinconcentration would be ~36 nM. Therefore, assuming
a stochastic clustering of labeled and unlabeled profilin,
the detection of dimers could indeed represent much larger
aggregates. To test whether labeled profilin could bind to
the GUV through nonspecific interactions, we added labeled
profilin to GUVs made of 100% POPC and found that there
was no binding of the profilin to the membrane, confirming
that the interaction is specific to PI(4,5)P2 (Fig. 3).FIGURE 3 Confocal microscopy
images of GUVs. (A) 5-IAF-labeled
profilin in the presence of a GUV made
of 100% POPC (average of 100 frames).
(B–F) GUV containing 99% POPC
and 1% BODIPY TMR-labeled
PI(4,5)P2 in the presence of profilin.
(D) Shmoo-like deformation of the
GUV. (B) Budding of the GUV and
the presence of lipid inclusions. (C)
Altered GUV after several hours in the
presence of profilin. (E and F) GUVs
grown in the presence of 10 mM profilin.Biophysical Journal 96(12) 5112–5121
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To our surprise, we found that although the GUV made of
1% BODIPY TMR PI(4,5)P2 in the absence of profilin could
still be observed after several days, when profilin was added,
the GUVs could not be seen after 36 h, and only clusters of
BODIPY TMR PI(4,5)P2 lipids were detected in the cham-
bers (data not shown). Looking at various intervals after
the addition of unlabeled profilin (70–100 mM), we noticed
that although not all GUVs were affected simultaneously,
a large proportion of GUVs showed altered morphology
(Fig. 3), including ‘‘shmoo-like’’ shapes, junctions between
GUVs, and budding of GUVs. These morphological changes
were accompanied by increased fluorescence intensity at the
site of junction or budding. No changes in the GUV
morphology were observed when profilin was added to
GUV made of POPC labeled with 1% DIiC18 (data not
shown), confirming that these changes resulted from the
interaction between profilin and PI(4,5)P2.
We further tested this mechanism by growing GUVs in
the presence of various amounts of unlabeled profilin
(10–100 mM). We found that GUVs were not electroformed
when profilin was present at concentrations above 10 mM.
Only a few GUVs were formed in the presence of 10 mM
profilin, but the shapes of these vesicles were dramatically
altered (Fig. 3).
Using brightness analysis, we investigated whether the
increased intensity at the site of altered morphology was due
to the presence of clusters of profilin or PI(4,5)P2 lipids, or
both. Fig. 4 demonstrates that both profilin and PI(4,5)P2
form clusters, and that these clusters are associated with sites
of membrane alterations. The cluster sizes determined from
the brightness of the labeled profilin range from 3 to 5.
However, as mentioned above, the size of these clusters is
underestimated due to the presence of unlabeled profilin. The
cluster size determined from the brightness of the BODIPY
TMR PI(4,5)P2 lipids can be much larger (up to 13). Unfortu-
nately, these do not represent the actual cluster size either.
Indeed, although each PI(4,5)P2 has a fluorescent label (unlike
profilin), BODIPYTMRPI(4,5)P2 has been shown to undergo
aggregation with subsequent self-quenching, and has been
used to monitor the interaction of MARCKS (25) and PTEN
(24) with PI(4,5)P2 in large vesicles. Such quenching would
result in an underestimation of the brightness of the aggregates
or clusters. If the BODIPY TMR self-quenching is due to
dynamic quenching, by measuring the lifetime of the cluster
(29) we could calculate the amount of quenching and thus
obtain a corrected value for the brightness of the clusters.
Self-quenching of BODIPY TMR PI(4,5)P2 is the
result of static quenching
In the presence of dynamic quenching, the quenching rate
constant kq can be calculated directly from the lifetime of
the fluorophores in the absence (t0) and presence (t) of
quencher [Q] according to the following equation:Biophysical Journal 96(12) 5112–5121t0
t
¼ 1 þ kqt0½Q: (1)
We therefore attempted to determine the lifetime in GUVs
in the absence of quenching (25), i.e., in GUVs made of 1%
BODIPY TMR PI(4,5)P2 and 99% POPC, and with GUVs
formedwith 100%BODIPYTMRPI(4,5)P2when quenching
FIGURE 4 Brightness analysis of a GUV in the presence of ~55 mM pro-
filin. (A, C, E, and G) GUV containing 99% POPC and 1% BODIPY TMR-
labeled PI(4,5)P2. (B, D, F, andH) 5-IAF-labeled profilin binding on a GUV
made of 99% POPC and 1% unlabeled PI(4,5)P2. (A and B) Intensity map of
the GUV. (C and D) The highlighted pixels correspond to the molecular
brightness of monomers. (E and F) The highlighted pixels have a higher
brightness and correspond to clusters in the membrane. (G andH) Brightness
map of the same GUVs.
Biophysical Journal 96(12) 5112–5121
Proﬁlin Destabilizes the GUV Membrane 5117would be maximal. The GUVs were grown simultaneously in
different wells of the same chamber. Upon observation with
the microscope, we found that whereas GUVs made of 1%
BODIPYTMRPI(4,5)P2 and 99%POPCwere nicely formed,
we could only detect BODIPY TMR PI(4,5)P2 lipid aggre-
gates in the wells of 100% BODIPY TMR PI(4,5)P2.
Although we did not produce GUVs when using 100%BOD-
IPYTMRPI(4,5)P2, these clusters could still be used to deter-
mine the lifetime in conditions of maximal quenching.
The measured fluorescence decay curves of the two
samples can be described by a double exponential decay.
The first lifetime component is ascribed to the fluorescence
from the probes, whereas the second component is consid-
ered to be a scattering signal with a quasi-zero lifetime.
This scattering component is not only necessary for the fit,
but additional scattering test measurements have confirmed
the unavoidable existence of scattered light under the chosen
measurement conditions (530 nm excitation and OG550
fluorescence filter). The 100% BODIPY TMR PI(4,5)P2
sample clearly exhibits a lifetime of 5 ns. The GUV made
with the 1%BODIPYTMRPI(4,5)P2 sample shows a similar
lifetime in the 5–6 ns range, but due to the extremely low
fluorescence intensity of this sample (and therefore
extremely long data collection times), the data quality does
not allow precise lifetime resolution. However, this lifetime
is in good agreement with a lifetime of 5.1 ns previously
determined for the short-chain (C6) BODIPY TMR
PI(4,5)P2 (7). The normalized emission and excitation
spectra of these samples (Fig. 5) show that there is a ~10 nm
blue shift of the absorption spectrum for the 100%
BODIPY TMR PI(4,5)P2. There is also a slight increase of
the intensity in the long-wavelength region. This increase
could represent emission from ground-state aggregates as
FIGURE 5 Excitation and emission spectrum of BODIPY TMR-labeled
PI(4,5)P2 in GUVs and aggregates. Traces A and D are the normalized exci-
tation and the emission spectrum of the lipid aggregates (100% BODIPY
TMR-labeled PI(4,5)P2), respectively. Traces B and C are the normalized
excitation and the emission spectrum of GUVs containing 99% POPC and
1% BODIPY TMR-labeled PI(4,5)P2, respectively.suggested by Bergstro¨m et al. (30). However, the fractional
intensity is so low for this component that we could not
resolve it from the lifetime measurements.
Effect of increasing concentrations of PI(4,5)P2
on the GUV membrane
Since GUVs could not be electroformed with 100%
BODIPY TMR PI(4,5)P2, we investigated the effect of
increasing concentrations of PI(4,5)P2 on the electroforma-
tion of GUVs. To eliminate a possible effect of the fluores-
cent probe, we kept the concentration of labeled PI(4,5)P2
constant at a 1% molar ratio and increased the ratio of
PI(4,5)P2 to POPC using unlabeled PI(4,5)P2. We found
that GUVs were not formed above 40% PI(4,5)P2, and at
40% only a few GUVs could be observed in the chamber
(Fig. 6, G and H). Below 4% PI(4,5)P2, there are no morpho-
logical alterations of the GUVs (Fig. 6, A and B). However,
when the molar ratio of PI(4,5)P2 is increased to 8–10%, one
starts to detect the formation of lipid aggregates and multive-
sicles (Fig. 6, C and D). These lipid aggregates and morpho-
logical alterations increase with the increased PI(4,5)P2
molar ratio, and at 16–20% PI(4,5)P2, lipid tubes are seen
extending from the membrane, and aggregates are numerous.
There are also large numbers of small vesicles inside larger
GUVs (Fig. 6, E and F). A brightness analysis of GUVs
containing 8% BODIPY TMR PI(4,5)P2 shows that there is
clustering of PI(4,5)P2 in the membrane. Fig. 7 shows that
areas of the membrane with different levels of brightness
can be isolated. The lowest brightness was found to be
B ¼ 1.071 (3550 photons/mol/s), which probably represents
monomers of PI(4,5)P2 (Fig. 7 B). The remainder of the
membrane could be separated into two populations with an
average brightness of B ¼ 1.376 (18800 photons/mol/s)
and B¼ 2.263 (63150 photons/mol/s), respectively. Because
of the self-quenching of the BODIPY TMR moiety, it is not
possible to determine the exact size of the aggregate.
However, this result provides evidence that at these high
PI(4,5)P2 molar ratios, these lipids self-aggregate into large
clusters.
DISCUSSION
Self-quenching of BODIPY TMR PI(4,5)P2
To calculate the size of molecular aggregates using bright-
ness analysis, the photon emission rate per molecule in the
clusters should be a multiple of the photon emission rate
determined for the monomer. Therefore, self-quenching as
reported for BODIPY TMR PI(4,5)P2 (24,25) would result
in an underestimation of the cluster size. However, if the
quenching rate can be determined from the fluorescence life-
time of the clusters, the emission rate in the cluster could be
corrected for the quenching process and the number of mole-
cules in the cluster recovered. The mechanism of self-
quenching for BODIPY-labeled phosphoinositides is still
5118 Krishnan et al.poorly characterized. Previous works used only steady-state
measurements to determine the quenching effect (24,25).
The mechanism of self-quenching for the headgroup-labeled
lipid N-(lissamine rhodamine B sulfonyl)dipalmitoylphos-
phatidylcholine was attributed to molecular interactions
(31), and the self-quenching mechanism for octadecyl
FIGURE 6 Confocal microscopy images of GUVs made of POPC and an
increasing concentration of PI(4,5)P2. The concentration of BODIPY TMR-
labeled PI(4,5)P2 is maintained constant at 1% molar ratio, and the increased
PI(4,5)P2 concentration is achieved by adding increasing amounts of
unlabeled PI(4,5)P2. (A and B) GUVs made with 1% and 2% PI(4,5)P2.
(C and D) GUVs containing 8% PI(4,5)P2. (E and F) GUVs containing
20% PI(4,5)P2. (G and H) The only GUVs formed in the chamber when
the PI(4,5)P2 concentration was 40% molar ratio.Biophysical Journal 96(12) 5112–5121rhodamine B was attributed to Fo¨rster resonance energy
transfer (32,33). In this work, we demonstrate that there
are no changes in the lifetime of the BODIPY TMR
PI(4,5)P2 between molecules in the absence of quencher or
in aggregates. Moreover, we show that there is a hypsochro-
mic shift of the excitation spectrum of the BODIPY TMR
PI(4,5)P2, which shows that these molecules are forming
ground-state complexes. However, the aggregates are still
fluorescent, which shows that the quenching is only partial.
These findings demonstrate that the self-quenching observed
is due to static quenching.
Recently, Bergstro¨m et al. (30) investigated the aggrega-
tion of BODIPY groups in a protein and lipid system.
Although they could clearly assign the type of dimers formed
in the protein system, it was less straightforward to interpret
the aggregation of BODIPY groups in the lipid system. An
additional complicating factor in our system is that the posi-
tion of the BODIPY group is much farther away from the
headgroup than in Bergstro¨m et al.’s experiments, which
would allow the formation of higher aggregates of BODIPY
(i.e., trimers, tetramers, etc.). Therefore it is not possible at
this stage to describe the type of aggregates present in our
system.
Since there were no changes in the lifetime of the
BODIPY TMR PI(4,5)P2 in the clusters, we could not deter-
mine the quenching rates in particular aggregates, and thus
could not establish a relationship between brightness and
cluster size. Nevertheless, we were able to demonstrate the
presence or absence of clusters and obtain the lowest
possible number of molecules forming these clusters.
Effect of an increased PI(4,5)P2 molar ratio
on the GUV membrane
Using lifetimemeasurements of diphenylhexatriene as a func-
tion of increasing concentration of NBD-labeled PI(4,5)P2 in
liposomes, Fernandes et al. (34) showed that below a 5%
molar ratio, the NBD-labeled PI(4,5)P2 is homogeneously
distributed in the POPC lipid matrix. In our experiments,
brightness analysis demonstrates that the labeled PI(4,5)P2
are uniformly distributed in the membrane, confirming that
there is no aggregation of PI(4,5)P2 in GUVs made with 1%
PI(4,5)P2. These results are also supported by the fact that
there is no self-quenching of the BODIPY-labeled PI(4,5)P2
below a 1% molar ratio (24,25). However, when the molar
ratio of the polyphosphoinositol lipids is increased toR8%,
dramatic changes in themembrane occur. Clear modifications
in the distribution of the fluorescence intensity within the
GUV membrane can be qualitatively observed. Also, for
molar ratios of PI(4,5)P2 of R20%, we noticed alterations
of the membrane morphology resulting in regions of high
fluorescence intensity and small lipid tubes or vesicles.
Brightness analysis was used to ascertain whether the regions
of increased intensity were due to an increased number of
molecules per pixel or to the aggregation of several
Proﬁlin Destabilizes the GUV Membrane 5119FIGURE 7 Brightness analysis of GUV made of 92%
POPC and 8% PI(4,5)P2. The concentration of BODIPY
TMR labeled PI(4,5)P2 was 1% molar ratio. (A) Fluores-
cence intensity map of the GUV. (B) The pixels highlighted
correspond to the molecular brightness of monomers
(1.071). (C) The highlighted pixels have an intermediate
brightness of 1.376 and correspond to clusters in the
membrane. (D) The highlighted pixels have the highest
brightness (2.263) and correspond to areas of larger
clusters.PI(4,5)P2 molecules. This analysis demonstrated that the
increased intensity was the result of molecular aggregation
of the PI(4,5)P2 lipids forming clusters within the GUV
membrane. These results suggest that there is a threshold of
the PI(4,5)P2 molar ratio between 5% and 8%, above which
these lipids start to aggregate and form clusters. The notion
of such lipid demixing in the fluid phase is supported by
previouswork. In 1981,Knoll et al. (35) reported immiscibility
in the fluid state. These authors reported that deprotonated
mixtures of distearoylphosphatidylcholine and dimyristoyl-
phosphatidylcholine-d54 above the liquidus line showed
a nonrandom lipid distribution in the fluid phase. They
attributed this lipid demixing to critical concentration fluctua-
tion. Also, using FRET between NBD-phosphatidylcholine
and BODIPY TMR PI(4,5)P2 in vesicles formed from
a PI(4,5)P2/POPC mixture, Redfern and Gericke (36) showed
a decrease in the acceptor/donor emission ratio as a function of
pH, suggesting the formation of fluid-type domains.
We also show that GUVs could not be formed when the
PI(4,5)P2 molar ratio exceeded 40%. Taken together, these
data suggest that the clustering of PI(4,5)P2 destabilizes the
GUV membrane. This result is in agreement with the work
of Carvalho et al. (8), who reported that the z-potential of
GUVs containing 15% cholesterol and 10% PI(4,5)P2
increased after five measurements, suggesting that GUVs
made of high levels of PI(4,5)P2 are more fragile. They also
reported that this effect was not observed for GUVs contain-
ing 5% PI(4,5)P2. These data suggest that in cells, a 10-foldlocal increase in PI(4,5)P2 concentration after, for instance,
protein translocation (37) or increased PI(4,5)P2 synthesis
(38) could result in self-aggregation of PI(4,5)P2. Since we
have shown that monodispersed PI(4,5)P2 has a low affinity
for profilin (7), PI(4,5)P2 clustering could dramatically
increase the chances of protein-lipid interaction by increasing
the association constant for such proteins severalfold. In addi-
tion, local increases in PI(4,5)P2 synthesis have been shown to
be essential for cell events that requiremembranemorpholog-
ical changes, such as membrane ruffling formation (38) and
endocytosis/exocytosis (10). Our findings suggest that
increased PI(4,5)P2 concentration and PI(4,5)P2 clustering
could destabilize the GUV membrane and contribute to the
local membrane deformation.
Proﬁlin destabilizes the GUV membrane
We demonstrate in this work that in the absence of PI(4,5)P2,
profilin does not bind to the GUV membrane. In the presence
of PI(4,5)P2, however, profilin is found to interact with the
membrane. In our experiments, profilin concentrations of
~55 mM were used, corresponding to the range of profilin
concentrations found in human platelets (30–50 mM) (39).
In the cell, these profilins would be associated with other
proteins, such as actin, and therefore free concentrations
would be much lower. Nevertheless, such concentrations
could be easily attained during local redistribution of proteins.
For example, Rawe et al. (18) found that profilin is observedBiophysical Journal 96(12) 5112–5121
5120 Krishnan et al.throughout the cytoplasm at all stages of early bovine devel-
opment through blastocyst formation, but it concentrates at
the cleavage furrow of bovine embryos. The association-
dissociation constant for the interaction between profilin
and PI(4,5)P2 micelles or liposomes has been reported to be
between 0.13 mM (40) and 35 mM (41). Therefore, by using
~55 mM profilin, we should maximize the interaction with
the membrane. The downside of using such concentrations
of profilin is that to image the binding of profilin to the
membrane and analyze the brightness of the particles, we
have to dilute the labeled profilin with unlabeled ones to
prevent image saturation. Because of the presence of unla-
beled profilin in the clusters, the number of profilin molecules
forming clusters could not be determined from the brightness
analysis. However, we show that profilin, similarly to
PI(4,5)P2, forms clusters on the membrane, and that these
clusters are also localized on the GUV membrane at the site
of morphological alterations. Furthermore, we show that
although GUVs made of 1% PI(4,5)P2 and 99% POPC are
stable, and PI(4,5)P2 does not form aggregates in these vesi-
cles, the addition of profilin induced the clustering of
PI(4,5)P2 and destabilized the GUV membrane, resulting in
the formation of shmoo, budding, and fusing vesicles, and
eventually the destruction of the GUVs. This destabilization
of the membrane is also supported by the profilin concentra-
tion dependence on the electroformation of the GUVs. It is
possible that the destabilization of the membrane leads to
the formation of multilamellar vesicles or multilamellar
regions in a vesicle, and that clusters form between bilayers.
However, this is unlikely since a brightness analysis of multi-
lamellar GUVs containing 1% PI(4,5)P2 did not show any
aggregation or clusters of PI(4,5)P2 (data not shown).
It is tempting to speculate that themembrane destabilization
effect seen upon self-clustering of PI(4,5)P2 is the same as that
seen in PI(4,5)P2 clustering due to profilin interaction;
however, thismight not be the case, and further studies to char-
acterize the destabilization of the membrane by PI(4,5)P2 in
the presence and absence of profilin are under way.
It has been demonstrated that clustering or segregation of
PI(4,5)P2 in GUVs can be induced by proteins other than pro-
filin.Bagatolli et al. (42) showed that dynamin II binds toGUV
composed of POPC/PI(4,5)P2 10:1 mol/mol. They demon-
strated that the protein distribution on the membrane was not
uniform, and the fluorescence was concentrated in patches
on the surface of the GUV. However, it is not clear whether
these patches were the result of self-aggregation of PI(4,5)P2
before dynamin binding or were induced by dynamin, since
clusters of PI(4,5)P2 are already present at an 8% mole ratio
(Fig. 7). Nevertheless, clusters resulting from the interaction
of proteins with PI(4,5)P2 have been clearly demonstrated
for annexin A2 (1) and ezrin (8). Of interest, none of these
proteins seem to have a destabilization effect on the GUV
membrane. Because the destabilization is a slow process,
a possible explanation for this difference could be the different
timeframes of observation used in the studies. Another possi-Biophysical Journal 96(12) 5112–5121bility is that the interaction of the proteins with PI(4,5)P2 form
different types of clusters that could lead to different functions.
This is supported by the fact that the interaction of ezrin with
PIP2 reduces ezrin’s hole-opening activity (4).
A possible explanation for the effect of profilin relies on the
binding stoichiometry of PI(4,5)P2 for profilin, and the small
size of the protein. Indeed, it has been shown that profilin
can bind up to five PI(4,5)P2 lipids (43) and that there are
multiple binding sites for PI(4,5)P2 on profilin (23,44). There-
fore, when multiple PI(4,5)P2 molecules bind to profilin, they
wrap around it, creating a local change in themembrane curva-
ture. The formation and aggregation of several of these
complexes could trigger a local destabilization of the
membrane. Of interest, both PI(4,5)P2 and profilin have now
been independently reported to accumulate at sites of
membrane deformation, such as cleavage furrow (13,14,18)
and endocytosis (10–12,45,46). The effects of profilin and
PI(4,5)P2 on the cell membrane suggest that these molecules
maywork cooperatively and facilitate these cellular processes.
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